Targeting NF-κB Signaling in Multiple Myeloma

被引：0
|
作者：
Bergsagel, P. Leif [1 ]
Keats, J. Jonathan [1 ]
Chesi, Marta [1 ]
Kuehl, W. Michael [2 ]
机构：
[1] Mayo Clin, Scottsdale, AZ USA
[2] NCI, Bethesda, MD 20892 USA
来源：
CLINICAL LYMPHOMA & MYELOMA | 2009年 / 9卷
关键词：
CELL-GROWTH; INHIBITOR; PATHWAY;
D O I：
10.1016/S1557-9190(11)70807-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S14 / S16
页数：3
相关论文
共 50 条
  • [21] Targeting signaling pathways in multiple myeloma: Pathogenesis and implication for treatments
    Hu, Jingping
    Hu, Wei-Xin
    CANCER LETTERS, 2018, 414 : 214 - 221
  • [22] Microbial-induced immunomodulation by targeting the NF-κB system
    Neish, Andrew S.
    Naumann, Michael
    TRENDS IN MICROBIOLOGY, 2011, 19 (12) : 596 - 605
  • [23] A novel small-molecule inhibitor of NF-κB signaling
    Nakajima, Hiroto
    Fujiwara, Hideyasu
    Furuichi, Yasuhiro
    Tanaka, Keiji
    Shimbara, Naoki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 368 (04) : 1007 - 1013
  • [24] From Innate Immunity to Inflammation: A Primer on Multiple Facets of NF-κB Signaling in COVID-19
    Pandey, Ashutosh
    Mishra, Abhinava K.
    PHYSIOLOGIA, 2022, 2 (02): : 34 - 45
  • [25] Keratocyte Differentiation Is Regulated by NF-κB and TGFβ Signaling Crosstalk
    Zhou, Xin
    Li, Junhong
    Backman, Ludvig J.
    Danielson, Patrik
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [26] IAPs: a central element in the NF-κB activating signaling pathway
    Cartier, Jessy
    Marivin, Arthur
    Berthelet, Jean
    Dubrez, Laurence
    M S-MEDECINE SCIENCES, 2012, 28 (01): : 69 - 75
  • [27] The Novel, Proteasome-Independent NF-κB Inhibitor V1810 Induces Apoptosis and Cell Cycle Arrest in Multiple Myeloma and Overcomes NF-κB-Mediated Drug Resistance
    Meinel, Felix G.
    Mandl-Weber, Sonja
    Baumann, Philipp
    Leban, Johann
    Schmidmaier, Ralf
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (02) : 300 - 310
  • [28] Future of Personalized Therapy Targeting Aberrant Signaling Pathways in Multiple Myeloma
    Anwer, Faiz
    Gee, Kevin Mathew
    Iftikhar, Ahmad
    Baig, Mirza
    Russ, Atlantis Dawn
    Saeed, Sabina
    Abu Zar, Muhammad
    Razzaq, Faryal
    Carew, Jennifer
    Nawrocki, Steffan
    Al-Kateb, Hussam
    Parr, Nadia Nunes Cavalcante
    McBride, Ali
    Valent, Jason
    Samaras, Christy
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (07) : 397 - 405
  • [29] Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy
    Wang, Yanmeng
    Vandewalle, Niels
    De Veirman, Kim
    Vanderkerken, Karin
    Menu, Eline
    De Bruyne, Elke
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [30] Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma
    Ang, Daniel A.
    Carter, Jean-Michel
    Deka, Kamalakshi
    Tan, Joel H. L.
    Zhou, Jianbiao
    Chen, Qingfeng
    Chng, Wee Joo
    Harmston, Nathan
    Li, Yinghui
    NATURE COMMUNICATIONS, 2024, 15 (01)
12345